Toolkit
Latest project information
HTA - 16/167/120
A UK multicentre randomised controlled trial to determine the efficacy of treatments for acute antibody mediated rejection in renal transplantation
Project title: A UK multicentre randomised controlled trial to determine the efficacy of treatments for acute antibody mediated rejection in renal transplantation
Call to action: 16/167 16/167 HTA CET, HTA EoI to Full Form, closing 5 April 2017
Research type: Primary Research
Chief investigator: Dr Michelle Willicombe
Contractor: Imperial College London
Cost: £1,455,032.64
Co-investigators: Dr Candice Roufosse, Dr David Game, Dr Edward Wilson, Dr Lorna Henderson, Dr Menna Clatworthy, Dr Nicholas Torpey, Dr Richard Baker, Dr Sian Griffin, Dr Stephen Marks, Dr Thomas Hiemstra, Mr Frank Clarke, Mr Simon Knight, Professor James Wason.
Started: September 2018 | Status: Research in progress
ISRCTN: 18179652
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research